Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia
The overlapping symptoms of behavioural variant frontotemporal dementia (bvFTD) and primary psychiatric disorders (such as depressive disorder, schizophrenia spectrum, and bipolar disorder) present a challenge for the differential diagnosis of bvFTD in middle and older-aged people. Neurofilaments ar...
Gespeichert in:
| Veröffentlicht in: | Journal of psychiatric research 2019-06, Vol.113, p.137-140 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 140 |
|---|---|
| container_issue | |
| container_start_page | 137 |
| container_title | Journal of psychiatric research |
| container_volume | 113 |
| creator | Al Shweiki, MHD Rami Steinacker, Petra Oeckl, Patrick Hengerer, Bastian Danek, Adrian Fassbender, Klaus Diehl-Schmid, Janine Jahn, Holger Anderl-Straub, Sarah Ludolph, Albert C. Schönfeldt-Lecuona, Carlos Otto, Markus |
| description | The overlapping symptoms of behavioural variant frontotemporal dementia (bvFTD) and primary psychiatric disorders (such as depressive disorder, schizophrenia spectrum, and bipolar disorder) present a challenge for the differential diagnosis of bvFTD in middle and older-aged people. Neurofilaments are cytoskeletal proteins in the neurons, and several studies have reported elevated levels of neurofilament light chain (NfL) in cerebrospinal fluid of neurodegenerative as well as psychiatric disorders. The study aims to determine the utility of serum NfL levels as a biomarker to differentiate between bvFTD and psychiatric disorder. In our study, we investigated the levels of NfL in the serum of schizophrenia (n = 11), depression (n = 28), bipolar (n = 11), bvFTD (n = 20) patients and controls (n = 27) by single molecule array (Simoa) technology. The schizophrenia, depression and bipolar patients did not show significant changes in serum NfL levels in comparison to the control group (p > 0.99). The serum NfL levels were significantly elevated in bvFTD patients in comparison to the control cohort (p |
| doi_str_mv | 10.1016/j.jpsychires.2019.03.019 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2204689367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022395619302079</els_id><sourcerecordid>2204689367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-3fbd30a5419fbbc7fbb5ce528cf4faaed46954049087cc03c9afe35a8a5fd91f3</originalsourceid><addsrcrecordid>eNqFUcuO1DAQtBCIHRZ-AfnIJaEd5-UjrFhAWsEFzlbHbjMekniwnZH2B_huPMwCRy5dUnd1ld3FGBdQCxD960N9OKZ7s_eRUt2AUDXIusAjthPjoCohB_WY7QCappKq66_Ys5QOADA0on3KriSoTo693LGfn2iLwfkZF1ozn_23feZmj37lmDjyaQ7B8smHBeN3ijwHbr1zFAvbYyZ-eQfm6E2ZpBAtxcRdDAufaI8nH7aIMz9h9FgMymDNIdNyDOe2peW30HP2xOGc6MUDXrOvt---3Hyo7j6__3jz5q4ycmhzJd1kJWDXCuWmyQyldIa6ZjSudYhk2151LbQKxsEYkEahI9nhiJ2zSjh5zV5ddI8x_NgoZb34ZGiecaWwJd000Pajkv1QqOOFamJIKZLTx-jLFe61AH1OQR_0vxT0OQUNUhcoqy8fXLZpIft38c_ZC-HthUDlrydPUSfjaTVki5bJ2gb_f5dfA9ejwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2204689367</pqid></control><display><type>article</type><title>Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia</title><source>Elsevier ScienceDirect Journals</source><creator>Al Shweiki, MHD Rami ; Steinacker, Petra ; Oeckl, Patrick ; Hengerer, Bastian ; Danek, Adrian ; Fassbender, Klaus ; Diehl-Schmid, Janine ; Jahn, Holger ; Anderl-Straub, Sarah ; Ludolph, Albert C. ; Schönfeldt-Lecuona, Carlos ; Otto, Markus</creator><creatorcontrib>Al Shweiki, MHD Rami ; Steinacker, Petra ; Oeckl, Patrick ; Hengerer, Bastian ; Danek, Adrian ; Fassbender, Klaus ; Diehl-Schmid, Janine ; Jahn, Holger ; Anderl-Straub, Sarah ; Ludolph, Albert C. ; Schönfeldt-Lecuona, Carlos ; Otto, Markus</creatorcontrib><description>The overlapping symptoms of behavioural variant frontotemporal dementia (bvFTD) and primary psychiatric disorders (such as depressive disorder, schizophrenia spectrum, and bipolar disorder) present a challenge for the differential diagnosis of bvFTD in middle and older-aged people. Neurofilaments are cytoskeletal proteins in the neurons, and several studies have reported elevated levels of neurofilament light chain (NfL) in cerebrospinal fluid of neurodegenerative as well as psychiatric disorders. The study aims to determine the utility of serum NfL levels as a biomarker to differentiate between bvFTD and psychiatric disorder. In our study, we investigated the levels of NfL in the serum of schizophrenia (n = 11), depression (n = 28), bipolar (n = 11), bvFTD (n = 20) patients and controls (n = 27) by single molecule array (Simoa) technology. The schizophrenia, depression and bipolar patients did not show significant changes in serum NfL levels in comparison to the control group (p > 0.99). The serum NfL levels were significantly elevated in bvFTD patients in comparison to the control cohort (p < 0.0001), depression (p < 0.0001), schizophrenia (p < 0.0002) and bipolar patients (p < 0.0083). We propose serum NfL as a biomarker to differentiate bvFTD from psychiatric disorders and to rule out neurodegeneration in the course of psychiatric disorders.</description><identifier>ISSN: 0022-3956</identifier><identifier>EISSN: 1879-1379</identifier><identifier>DOI: 10.1016/j.jpsychires.2019.03.019</identifier><identifier>PMID: 30953863</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biomarker ; Bipolar ; bvFTD ; Depression ; Frontotemporal dementia ; Psychiatric disorders ; Schizophrenia ; Serum NFL ; Simoa</subject><ispartof>Journal of psychiatric research, 2019-06, Vol.113, p.137-140</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-3fbd30a5419fbbc7fbb5ce528cf4faaed46954049087cc03c9afe35a8a5fd91f3</citedby><cites>FETCH-LOGICAL-c374t-3fbd30a5419fbbc7fbb5ce528cf4faaed46954049087cc03c9afe35a8a5fd91f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022395619302079$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30953863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al Shweiki, MHD Rami</creatorcontrib><creatorcontrib>Steinacker, Petra</creatorcontrib><creatorcontrib>Oeckl, Patrick</creatorcontrib><creatorcontrib>Hengerer, Bastian</creatorcontrib><creatorcontrib>Danek, Adrian</creatorcontrib><creatorcontrib>Fassbender, Klaus</creatorcontrib><creatorcontrib>Diehl-Schmid, Janine</creatorcontrib><creatorcontrib>Jahn, Holger</creatorcontrib><creatorcontrib>Anderl-Straub, Sarah</creatorcontrib><creatorcontrib>Ludolph, Albert C.</creatorcontrib><creatorcontrib>Schönfeldt-Lecuona, Carlos</creatorcontrib><creatorcontrib>Otto, Markus</creatorcontrib><title>Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia</title><title>Journal of psychiatric research</title><addtitle>J Psychiatr Res</addtitle><description>The overlapping symptoms of behavioural variant frontotemporal dementia (bvFTD) and primary psychiatric disorders (such as depressive disorder, schizophrenia spectrum, and bipolar disorder) present a challenge for the differential diagnosis of bvFTD in middle and older-aged people. Neurofilaments are cytoskeletal proteins in the neurons, and several studies have reported elevated levels of neurofilament light chain (NfL) in cerebrospinal fluid of neurodegenerative as well as psychiatric disorders. The study aims to determine the utility of serum NfL levels as a biomarker to differentiate between bvFTD and psychiatric disorder. In our study, we investigated the levels of NfL in the serum of schizophrenia (n = 11), depression (n = 28), bipolar (n = 11), bvFTD (n = 20) patients and controls (n = 27) by single molecule array (Simoa) technology. The schizophrenia, depression and bipolar patients did not show significant changes in serum NfL levels in comparison to the control group (p > 0.99). The serum NfL levels were significantly elevated in bvFTD patients in comparison to the control cohort (p < 0.0001), depression (p < 0.0001), schizophrenia (p < 0.0002) and bipolar patients (p < 0.0083). We propose serum NfL as a biomarker to differentiate bvFTD from psychiatric disorders and to rule out neurodegeneration in the course of psychiatric disorders.</description><subject>Biomarker</subject><subject>Bipolar</subject><subject>bvFTD</subject><subject>Depression</subject><subject>Frontotemporal dementia</subject><subject>Psychiatric disorders</subject><subject>Schizophrenia</subject><subject>Serum NFL</subject><subject>Simoa</subject><issn>0022-3956</issn><issn>1879-1379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFUcuO1DAQtBCIHRZ-AfnIJaEd5-UjrFhAWsEFzlbHbjMekniwnZH2B_huPMwCRy5dUnd1ld3FGBdQCxD960N9OKZ7s_eRUt2AUDXIusAjthPjoCohB_WY7QCappKq66_Ys5QOADA0on3KriSoTo693LGfn2iLwfkZF1ozn_23feZmj37lmDjyaQ7B8smHBeN3ijwHbr1zFAvbYyZ-eQfm6E2ZpBAtxcRdDAufaI8nH7aIMz9h9FgMymDNIdNyDOe2peW30HP2xOGc6MUDXrOvt---3Hyo7j6__3jz5q4ycmhzJd1kJWDXCuWmyQyldIa6ZjSudYhk2151LbQKxsEYkEahI9nhiJ2zSjh5zV5ddI8x_NgoZb34ZGiecaWwJd000Pajkv1QqOOFamJIKZLTx-jLFe61AH1OQR_0vxT0OQUNUhcoqy8fXLZpIft38c_ZC-HthUDlrydPUSfjaTVki5bJ2gb_f5dfA9ejwA</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Al Shweiki, MHD Rami</creator><creator>Steinacker, Petra</creator><creator>Oeckl, Patrick</creator><creator>Hengerer, Bastian</creator><creator>Danek, Adrian</creator><creator>Fassbender, Klaus</creator><creator>Diehl-Schmid, Janine</creator><creator>Jahn, Holger</creator><creator>Anderl-Straub, Sarah</creator><creator>Ludolph, Albert C.</creator><creator>Schönfeldt-Lecuona, Carlos</creator><creator>Otto, Markus</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201906</creationdate><title>Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia</title><author>Al Shweiki, MHD Rami ; Steinacker, Petra ; Oeckl, Patrick ; Hengerer, Bastian ; Danek, Adrian ; Fassbender, Klaus ; Diehl-Schmid, Janine ; Jahn, Holger ; Anderl-Straub, Sarah ; Ludolph, Albert C. ; Schönfeldt-Lecuona, Carlos ; Otto, Markus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-3fbd30a5419fbbc7fbb5ce528cf4faaed46954049087cc03c9afe35a8a5fd91f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomarker</topic><topic>Bipolar</topic><topic>bvFTD</topic><topic>Depression</topic><topic>Frontotemporal dementia</topic><topic>Psychiatric disorders</topic><topic>Schizophrenia</topic><topic>Serum NFL</topic><topic>Simoa</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al Shweiki, MHD Rami</creatorcontrib><creatorcontrib>Steinacker, Petra</creatorcontrib><creatorcontrib>Oeckl, Patrick</creatorcontrib><creatorcontrib>Hengerer, Bastian</creatorcontrib><creatorcontrib>Danek, Adrian</creatorcontrib><creatorcontrib>Fassbender, Klaus</creatorcontrib><creatorcontrib>Diehl-Schmid, Janine</creatorcontrib><creatorcontrib>Jahn, Holger</creatorcontrib><creatorcontrib>Anderl-Straub, Sarah</creatorcontrib><creatorcontrib>Ludolph, Albert C.</creatorcontrib><creatorcontrib>Schönfeldt-Lecuona, Carlos</creatorcontrib><creatorcontrib>Otto, Markus</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of psychiatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al Shweiki, MHD Rami</au><au>Steinacker, Petra</au><au>Oeckl, Patrick</au><au>Hengerer, Bastian</au><au>Danek, Adrian</au><au>Fassbender, Klaus</au><au>Diehl-Schmid, Janine</au><au>Jahn, Holger</au><au>Anderl-Straub, Sarah</au><au>Ludolph, Albert C.</au><au>Schönfeldt-Lecuona, Carlos</au><au>Otto, Markus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia</atitle><jtitle>Journal of psychiatric research</jtitle><addtitle>J Psychiatr Res</addtitle><date>2019-06</date><risdate>2019</risdate><volume>113</volume><spage>137</spage><epage>140</epage><pages>137-140</pages><issn>0022-3956</issn><eissn>1879-1379</eissn><abstract>The overlapping symptoms of behavioural variant frontotemporal dementia (bvFTD) and primary psychiatric disorders (such as depressive disorder, schizophrenia spectrum, and bipolar disorder) present a challenge for the differential diagnosis of bvFTD in middle and older-aged people. Neurofilaments are cytoskeletal proteins in the neurons, and several studies have reported elevated levels of neurofilament light chain (NfL) in cerebrospinal fluid of neurodegenerative as well as psychiatric disorders. The study aims to determine the utility of serum NfL levels as a biomarker to differentiate between bvFTD and psychiatric disorder. In our study, we investigated the levels of NfL in the serum of schizophrenia (n = 11), depression (n = 28), bipolar (n = 11), bvFTD (n = 20) patients and controls (n = 27) by single molecule array (Simoa) technology. The schizophrenia, depression and bipolar patients did not show significant changes in serum NfL levels in comparison to the control group (p > 0.99). The serum NfL levels were significantly elevated in bvFTD patients in comparison to the control cohort (p < 0.0001), depression (p < 0.0001), schizophrenia (p < 0.0002) and bipolar patients (p < 0.0083). We propose serum NfL as a biomarker to differentiate bvFTD from psychiatric disorders and to rule out neurodegeneration in the course of psychiatric disorders.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30953863</pmid><doi>10.1016/j.jpsychires.2019.03.019</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-3956 |
| ispartof | Journal of psychiatric research, 2019-06, Vol.113, p.137-140 |
| issn | 0022-3956 1879-1379 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2204689367 |
| source | Elsevier ScienceDirect Journals |
| subjects | Biomarker Bipolar bvFTD Depression Frontotemporal dementia Psychiatric disorders Schizophrenia Serum NFL Simoa |
| title | Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A05%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurofilament%20light%20chain%20as%20a%20blood%20biomarker%20to%20differentiate%20psychiatric%20disorders%20from%20behavioural%20variant%20frontotemporal%20dementia&rft.jtitle=Journal%20of%20psychiatric%20research&rft.au=Al%20Shweiki,%20MHD%20Rami&rft.date=2019-06&rft.volume=113&rft.spage=137&rft.epage=140&rft.pages=137-140&rft.issn=0022-3956&rft.eissn=1879-1379&rft_id=info:doi/10.1016/j.jpsychires.2019.03.019&rft_dat=%3Cproquest_cross%3E2204689367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2204689367&rft_id=info:pmid/30953863&rft_els_id=S0022395619302079&rfr_iscdi=true |